-
Posted by
Two Blokes Jun 24 -
Filed in
Stock
-
3 views
Registration Link for Presentation and live Q&A to take place, Monday, June 30, 2025 at 10:00 am EST Marlborough, Massachusetts--(Newsfile Corp. - June 24, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL\u00ae gene silencing technology to eliminate cancer. Phio announced today that Mr.
